Physician profile
Benjamin Batson
NPI 1699296954
$7,162.28
in general payments reported to CMS, 2019-2025
28 companies · $2,963 in 2025
The $2,963 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $528 · 2022: $369 · 2023: $952 · 2024: $2,351 · 2025: $2,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,855 · Travel and Lodging: $394 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,855.28 |
| Travel and Lodging | $394.16 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,825.94 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,559.46 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $713.35 | 2021-2025 | Ofev |
| Amgen INC. | $603.34 | 2021-2025 | Tezspire |
| Intuitive Surgical, INC. | $468.46 | 2025 | |
| Grifols USA, LLC | $342.00 | 2022-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $290.31 | 2025 | Ohtuvayre |
| Insmed, INC. | $254.85 | 2025 | Arikayce, Brinsupri |
| Abiomed | $184.96 | 2024-2025 | Impella |
| Baxter Healthcare | $184.20 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $99.84 | 2023-2024 | Yupelri |
| Genzyme Corporation | $91.60 | 2023-2024 | |
| Olympus America INC. | $87.05 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $55.64 | 2024-2025 | Dupixent |
| Electromed, INC. | $53.68 | 2025 | Smartvest |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $52.47 | 2023-2025 | Tyvaso, Tyvaso |
| Viatris Specialty LLC | $41.77 | 2025 | Yupelri |
| Inari Medical, INC. | $39.85 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inspire Medical Systems, INC. | $32.58 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $29.28 | 2023-2024 | Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $28.97 | 2024 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $22.45 | 2025 | |
| Pfizer INC. | $20.37 | 2023 | |
| Janssen Pharmaceuticals, INC | $17.60 | 2024 | Xarelto |
| Movair INC | $17.25 | 2025 | Luisa |
| Alexion Pharmaceuticals, INC. | $16.45 | 2022 | |
| Genentech USA, INC. | $14.28 | 2023 | Xolair |
| Mallinckrodt Hospital Products INC. | $14.28 | 2025 | Terlivaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Batson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.